Rapifen
Rapifen is a medicine authorised by Swissmedic under authorisation number 45204. The authorisation holder is Piramal Critical Care Limited, London, Zweigniederlassung Rüschlikon. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 12 August 1983 and the authorisation is valid without a time limit. ATC code N01AH02 places the medicine in the group Anesthetics.
| Authorisation number | 45204 |
|---|---|
| Name | Rapifen |
| Full name | Rapifen, Injektions-/Infusionslösung |
| Authorisation holder | Piramal Critical Care Limited, London, Zweigniederlassung Rüschlikon |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N01AH02 |
| First authorisation | 12 August 1983 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rapifen, Injektions-/Infusionslösung | A+ | 12 August 1983 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 x 2 ml | Ampulle(n) | N01AH02 | 01.01.3. | A+ |
| 2 | 10 x 10 ml | Ampulle(n) | N01AH02 | 01.01.3. | A+ |
| 14 | 5 x 2 ml | Ampulle(n) | N01AH02 | 01.01.3. | A+ |
| 49 | 50 x 10 ml | Ampulle(n) | N01AH02 | 01.01.3. | A+ |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rapifen authorised in Switzerland?
Yes. Rapifen is authorised by Swissmedic under authorisation number 45204, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rapifen have?
Rapifen is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Rapifen?
The authorisation holder is Piramal Critical Care Limited, London, Zweigniederlassung Rüschlikon. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.